CA1209504A - Extrait de microorganisme soluble dans la pyridine - Google Patents

Extrait de microorganisme soluble dans la pyridine

Info

Publication number
CA1209504A
CA1209504A CA000430780A CA430780A CA1209504A CA 1209504 A CA1209504 A CA 1209504A CA 000430780 A CA000430780 A CA 000430780A CA 430780 A CA430780 A CA 430780A CA 1209504 A CA1209504 A CA 1209504A
Authority
CA
Canada
Prior art keywords
pyridine
extract
soluble extract
microorganism
weight
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
CA000430780A
Other languages
English (en)
Inventor
John L. Cantrell
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Ribi Immunochem Research Inc
Original Assignee
Ribi Immunochem Research Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ribi Immunochem Research Inc filed Critical Ribi Immunochem Research Inc
Application granted granted Critical
Publication of CA1209504A publication Critical patent/CA1209504A/fr
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00—Preparation of peptides or proteins
    • C12P21/005—Glycopeptides, glycoproteins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • C12N1/205—Bacterial isolates
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P1/00—Preparation of compounds or compositions, not provided for in groups C12P3/00 - C12P39/00, by using microorganisms or enzymes
    • C12P1/04—Preparation of compounds or compositions, not provided for in groups C12P3/00 - C12P39/00, by using microorganisms or enzymes by using bacteria
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P1/00—Preparation of compounds or compositions, not provided for in groups C12P3/00 - C12P39/00, by using microorganisms or enzymes
    • C12P1/06—Preparation of compounds or compositions, not provided for in groups C12P3/00 - C12P39/00, by using microorganisms or enzymes by using actinomycetales
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • C12R2001/15—Corynebacterium
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • C12R2001/32—Mycobacterium
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • C12R2001/365—Nocardia

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Mycology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Molecular Biology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Epidemiology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Virology (AREA)
  • Biomedical Technology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
CA000430780A 1982-06-30 1983-06-20 Extrait de microorganisme soluble dans la pyridine Expired CA1209504A (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US39382182A 1982-06-30 1982-06-30
US393,821 1982-06-30

Publications (1)

Publication Number Publication Date
CA1209504A true CA1209504A (fr) 1986-08-12

Family

ID=23556385

Family Applications (1)

Application Number Title Priority Date Filing Date
CA000430780A Expired CA1209504A (fr) 1982-06-30 1983-06-20 Extrait de microorganisme soluble dans la pyridine

Country Status (6)

Country Link
JP (1) JPS5917990A (fr)
CA (1) CA1209504A (fr)
DE (1) DE3323094A1 (fr)
FR (1) FR2534271B1 (fr)
GB (1) GB2123006B (fr)
IT (1) IT1163622B (fr)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4663306A (en) * 1983-09-23 1987-05-05 Ribi Immunochem Research, Inc. Pyridine-soluble extract-refined detoxified endotoxin composition and use
US8640414B2 (en) 2006-05-24 2014-02-04 II Robert A. Reyes Fully insulated glass panel rolling door

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3529057A (en) * 1964-08-14 1970-09-15 Takeda Chemical Industries Ltd Purified periodic acid-oxidized mucopeptide of mycobacteria cell walls constituting a vaccine enhancing nonspecific host resistance against pathogenic bacterial infections
NL7308450A (fr) * 1972-06-20 1973-12-27
US3976544A (en) * 1973-06-19 1976-08-24 The Agence Nationale De Valorisation De Le Recherche Water-soluble immunological adjuvants, in particular for vaccines, obtained from mycobacteria and related microorganisms and process for their extraction
JPS5624513A (en) * 1979-08-03 1981-03-09 Mitsubishi Heavy Ind Ltd Composite displaying device for navigation
JPS58874B2 (ja) * 1979-08-30 1983-01-08 株式会社 目黒研究所 糖蛋白ｗｅｎａｃ及びその製造法
JPS57165320A (en) * 1981-04-06 1982-10-12 Sanraku Inc Antitumor agent

Also Published As

Publication number Publication date
DE3323094A1 (de) 1984-01-05
GB2123006B (en) 1985-08-29
IT1163622B (it) 1987-04-08
IT8321852A0 (it) 1983-06-29
IT8321852A1 (it) 1984-12-29
FR2534271A1 (fr) 1984-04-13
FR2534271B1 (fr) 1988-06-17
GB8317743D0 (en) 1983-08-03
DE3323094C2 (fr) 1988-09-29
GB2123006A (en) 1984-01-25
JPS5917990A (ja) 1984-01-30

Similar Documents

Publication Publication Date Title
DE3833319C2 (fr)
CA1217136A (fr) Endotoxine detoxifiee et raffinee
US4436727A (en) Refined detoxified endotoxin product
US4520019A (en) Stable composition and preparation thereof
US4505900A (en) Refined detoxified endotoxin product
CH664897A5 (de) Gereinigtes, entgiftetes endotoxin enthaltende pharmazeutische zusammensetzung.
US4504473A (en) Pyridine soluble extract of a microorganism
CA1135640A (fr) Substance anti-tumorale et procede de preparation
US4239498A (en) Method of preparing thymic factors and composition
US4505903A (en) Pyridine soluble extract of a microorganism
US4503048A (en) Pyridine soluble extract of a microorganism
DE69014543T2 (de) Multivalentes immunogen lmi.
CA1209504A (fr) Extrait de microorganisme soluble dans la pyridine
CA1206416A (fr) Extrait de pyridine soluble provenant de microorganismes
CA1206415A (fr) Extrait de pyridine soluble provenant de microorganismes
DD222895A5 (de) Verfahren zur herstellung eines hypotriglyceridemisch aktiven polysaccharids
EP0015846A2 (fr) Fraction antigénique sub-cellulaire de la paroi cellulaire de Bordetella Bronchiseptica, procédé pour sa préparation et composition la contenant
US4613504A (en) Pyridine-soluble extracts of microorganisms
CA1202903A (fr) Composition stable, et sa preparation
Kelly et al. Effect of incubation with rabbit serum on toxicity and tumor-necrotizing action of polysaccharide from S. marcescens
EP0002645B1 (fr) Complexe antigénique de neisseria gonorrhoeae, procédé et vaccin
DE2713271A1 (de) Mitogene mittel, die insbesondere von bakterien-peptidoglykanen stammen
Smith et al. Death in mice induced by Staphylococcus aureus protoplasm
DE2520407A1 (de) Biologische extrakte und verfahren zu ihrer herstellung
JPS6129716B2 (fr)

Legal Events

Date Code Title Description
MKEX Expiry